Cybin Inc (CYBN) Prices 24.26M Unit Offering at $0.34/sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- Nasdaq notches record high close as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
- Citi cuts investment banking analyst program to two years - Bloomberg
- Alaska LNG shipping savings justifies billions in investment, developer says
- Paramount Skydance to close WBD deal, change ticker to SKYD
- Nasdaq notches record high close as investors focus on earnings
- This multi-trillion stock is "cheap and getting cheaper": Morgan Stanley
Cybin Announces Size and Pricing of Previously Announced Overnight Marketed Public Offering of Units
August 1, 2023 9:32 AM EDTTORONTO--(BUSINESS WIRE)-- Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) (Cybin or the Company), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment options, announced today the pricing of its previously announced overnight marketed public offering (the Offering) of an aggregate of 24,264,706 units of the Company (the Units) at a price of US$0.34 per Unit for aggregate gross proceeds of US$8,250,000.
Each Unit will be comprised of one common share in the capital of the Company (a Common... More



